V001-BCMA
Idiopathic Pulmonary Fibrosis · China Registry
Clinical trials
1
Mechanism
China Registry
Developer
Tongji Hospital
Overview
V001-BCMA is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via china registry. It appears in 1 tracked IPF clinical trial.
V001-BCMA clinical trials
Explore related
Medical disclaimer. This page summarizes research about V001-BCMA for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.